Previous studies have confirmed that inhibiting the interaction between TRIM33 and HSPB5 can restore the effect of TRIM33 on the TGF-β1 pathway and may be important for the treatment of IPF [12]. The gene discussed is CRYAB; the disease is idiopathic pulmonary fibrosis.